Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8828629rdf:typepubmed:Citationlld:pubmed
pubmed-article:8828629lifeskim:mentionsumls-concept:C0031485lld:lifeskim
pubmed-article:8828629lifeskim:mentionsumls-concept:C0596563lld:lifeskim
pubmed-article:8828629pubmed:dateCreated1997-1-13lld:pubmed
pubmed-article:8828629pubmed:abstractTextChildren treated for phenylketonuria (PKU) have a low intake of whole animal foods. Consequently, the dietary intake of long-chain polyunsaturated fatty acids (PUFA) is just a few milligrams per day, mostly represented by arachidonic acid (AA). In a consecutive series of studies, we assessed in treated PKU children their long-chain PUFA status, the AA-related eicosanoid synthesis and the effects of specific PUFA supplementations. We found that the good compliance with the dietary regimen negatively influences the long-chain PUFA status and serum eicosanoid release from platelets. Supplementation with either marine or blackcurrant oils modifies the long-chain PUFA status of PKU children without approaching the fatty acid pattern of a healthy control population. Good-compliant PKU patients have diet-related, low levels of circulating long-chain PUFA, whose clinical and functional consequences deserve further investigation. The effects of dietary supplementations with long-chain PUFA of both the n-6 and n-3 series should be carefully evaluated.lld:pubmed
pubmed-article:8828629pubmed:languageenglld:pubmed
pubmed-article:8828629pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8828629pubmed:citationSubsetIMlld:pubmed
pubmed-article:8828629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8828629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8828629pubmed:statusMEDLINElld:pubmed
pubmed-article:8828629pubmed:monthJullld:pubmed
pubmed-article:8828629pubmed:issn0340-6199lld:pubmed
pubmed-article:8828629pubmed:authorpubmed-author:GiovanniniMMlld:pubmed
pubmed-article:8828629pubmed:authorpubmed-author:RivaEElld:pubmed
pubmed-article:8828629pubmed:authorpubmed-author:TrojanSSlld:pubmed
pubmed-article:8828629pubmed:authorpubmed-author:BiasucciGGlld:pubmed
pubmed-article:8828629pubmed:authorpubmed-author:AgostoniCClld:pubmed
pubmed-article:8828629pubmed:authorpubmed-author:LuottiDDlld:pubmed
pubmed-article:8828629pubmed:authorpubmed-author:RottoliAAlld:pubmed
pubmed-article:8828629pubmed:issnTypePrintlld:pubmed
pubmed-article:8828629pubmed:volume155 Suppl 1lld:pubmed
pubmed-article:8828629pubmed:ownerNLMlld:pubmed
pubmed-article:8828629pubmed:authorsCompleteYlld:pubmed
pubmed-article:8828629pubmed:paginationS132-5lld:pubmed
pubmed-article:8828629pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8828629pubmed:meshHeadingpubmed-meshheading:8828629-...lld:pubmed
pubmed-article:8828629pubmed:meshHeadingpubmed-meshheading:8828629-...lld:pubmed
pubmed-article:8828629pubmed:meshHeadingpubmed-meshheading:8828629-...lld:pubmed
pubmed-article:8828629pubmed:meshHeadingpubmed-meshheading:8828629-...lld:pubmed
pubmed-article:8828629pubmed:meshHeadingpubmed-meshheading:8828629-...lld:pubmed
pubmed-article:8828629pubmed:meshHeadingpubmed-meshheading:8828629-...lld:pubmed
pubmed-article:8828629pubmed:meshHeadingpubmed-meshheading:8828629-...lld:pubmed
pubmed-article:8828629pubmed:meshHeadingpubmed-meshheading:8828629-...lld:pubmed
pubmed-article:8828629pubmed:meshHeadingpubmed-meshheading:8828629-...lld:pubmed
pubmed-article:8828629pubmed:meshHeadingpubmed-meshheading:8828629-...lld:pubmed
pubmed-article:8828629pubmed:year1996lld:pubmed
pubmed-article:8828629pubmed:articleTitleFatty acid metabolism in phenylketonuria.lld:pubmed
pubmed-article:8828629pubmed:affiliationDepartment of Paediatrics, San Paolo Biomedical Institute, Milan, Italy.lld:pubmed
pubmed-article:8828629pubmed:publicationTypeJournal Articlelld:pubmed